N-Boc-piperidine-4-boronic Acid Pinacol Ester
Product Information
Molecular Formula
C16H30NO4B
Molecular Weight
311.22
Description
N-Boc-piperidine-4-boronic Acid Pinacol Ester (CAS# 1048970-17-7) is a useful research chemical.
Synonyms
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-piperidinecarboxylic acid tert-butyl ester; tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate
IUPAC Name
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate
SMILES
B1(OC(C(O1)(C)C)(C)C)C2CCN(CC2)C(=O)OC(C)(C)C
InChI
InChI=1S/C16H30BNO4/c1-14(2,3)20-13(19)18-10-8-12(9-11-18)17-21-15(4,5)16(6,7)22-17/h12H,8-11H2,1-7H3
InChI Key
IBLQMWKHENBVJE-UHFFFAOYSA-N
Boiling Point
358.8 °C at 760 mmHg
Melting Point
60-65 °C
Flash Point
Not applicable
Purity
97 %
Density
1.03 g/cm3
Storage
2-8 °C
LogP
3.41760
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Signal Word
Warning
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
3
Exact Mass
311.2267886 g/mol
Monoisotopic Mass
311.2267886 g/mol
Topological Polar Surface Area
48Ų
Heavy Atom Count
22
Formal Charge
0
Complexity
406
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113493490-A | Synthetic peptide amide compound and application thereof in medical field | 2020-04-03 |
| WO-2021197283-A1 | Synthetic peptide amide compound and its use in the field of medicine | 2020-04-03 |
| WO-2021159993-A1 | Inhibitors of interleukin-1 receptor associated kinase (irak) /fms-like receptor tyrosine kinase (flt3), pharmaceutical products thereof, and methods thereof | 2020-02-14 |
| CN-110790817-A | Polypeptide compound, preparation, pharmaceutical composition, preparation method and application | 2019-11-12 |
| CN-111233974-A | Polypeptide compound, pharmaceutical composition, preparation method and application | 2019-11-12 |
| CN-111233974-B | Polypeptide compound, pharmaceutical composition, preparation method and application | 2019-11-12 |
| EP-3825322-A1 | Polypeptide compound, pharmaceutical composition, preparation method and application thereof | 2019-11-12 |
| US-2021139537-A1 | Polypeptide compound, pharmaceutical composition, preparation method and application thereof | 2019-11-12 |
| WO-2021093695-A1 | Polypeptide compound, pharmaceutical composition, preparation method and application thereof | 2019-11-12 |
| WO-2021012717-A1 | Antitumor compound used as axl inhibitor and use thereof | 2019-07-19 |
